You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, Mantle-Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Shanghai, Shanghai, China
    Ruijin Hospital
Nov 14, 2023

Patient Perspectives in Mantle Cell Lymphoma Clinical Research

Not yet recruiting
  • Mantle Cell Lymphoma
    • San Francisco, California
      Power Life Sciences
    Sep 15, 2023

    Mantle Cell Lymphoma Trial in Miami, Houston (Zanubrutinib, Tafasitamab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • Miami, Florida
    • +1 more
    Aug 31, 2023

    Mantle-cell Lymphoma Trial (Polatuzumab, bendamustin und rituximab)

    Not yet recruiting
    • Mantle-cell Lymphoma
    • Polatuzumab, bendamustin und rituximab
    • (no location specified)
    May 11, 2023

    Lymphoma Trial in Beijing, Shanghai City, Seoul (Obinutuzumab, Glofitamab, Rituximab)

    Recruiting
    • Lymphoma
    • Beijing, China
    • +2 more
    Oct 12, 2023

    Mantle Cell Lymphoma, Lymphoma, Mantle Cell Trial run by the NCI (EPOCH-R, GM-CSF, Idiotype vaccine)

    Completed
    Has Results
    • Mantle Cell Lymphoma
    • Lymphoma, Mantle Cell
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 4, 2023

    Mantle Cell Lymphoma Refractory Trial (Ibrutinib, Venetoclax, Navitoclax)

    Not yet recruiting
    • Mantle Cell Lymphoma Refractory
    • (no location specified)
    May 16, 2023

    Mantle Cell Lymphoma, Mantle Cell Lymphoma Refractory Trial (Glofitamab, Pirtobrutinib, Obinutuzumab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • Mantle Cell Lymphoma Refractory
    • (no location specified)
    Apr 18, 2023

    Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

    Not yet recruiting
    • Follicular Lymphoma
    • +3 more
    • Tazemetostat Pill
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Jun 28, 2023

    Mantle Cell Lymphoma Trial (drug, biological, other, procedure)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • (no location specified)
    Jul 26, 2023

    Mantle Cell Lymphoma Trial (Zanubrutinib, Rituximab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • (no location specified)
    Nov 22, 2022

    Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell Trial in United Kingdom (ALETA-001)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • +4 more
    • Birmingham, United Kingdom
    • +5 more
    Sep 18, 2023

    Mantle Cell Lymphoma Trial (Acalabrutinib, Rituximab)

    Not yet recruiting
    • Mantle Cell Lymphoma
    • (no location specified)
    Oct 31, 2022

    Lymphoma, B-Cell, Relapsed Cancer, Refractory Lymphoma Trial in Boston (Adaptive Bridging Radiation Therapy (ABRT))

    Not yet recruiting
    • Lymphoma, B-Cell
    • +7 more
    • Adaptive Bridging Radiation Therapy (ABRT)
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Aug 16, 2023

    Rituximab, Lenalidomide, Zebutinib ,Mantle Cell Lymphoma Trial in Hangzhou (ZR2 RDHAP)

    Recruiting
    • Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma
    • ZR2 RDHAP
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Aug 8, 2023

    Diffuse Large B Cell Lymphoma, Transformed Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma Trial (FT596, Cyclophosphamide,

    Withdrawn
    • Diffuse Large B Cell Lymphoma
    • +4 more
    • (no location specified)
    Jun 28, 2023

    Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Low Dose Radiation Therapy)

    Recruiting
    • Recurrent Mantle Cell Lymphoma
    • Refractory Mantle Cell Lymphoma
    • Low Dose Radiation Therapy
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 30, 2023

    Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (Pirtobrutinib, LV20.19 CAR T cells)

    Not yet recruiting
    • Non Hodgkin Lymphoma
    • +5 more
    • (no location specified)
    Aug 4, 2023

    Follicular Lymphoma, Mantle Cell Lymphoma Trial in Rouen (Determination of COVID-19 vacciantion efficacy)

    Completed
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Determination of COVID-19 vacciantion efficacy
    • Rouen, France
      Centre Henri Becquerel
    Dec 22, 2022

    Acute Myeloid Leukemia, Lymphoma, Mantle-Cell Trial (PEP07)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Lymphoma, Mantle-Cell
    • (no location specified)
    Dec 22, 2022

    B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Non-Interventional Study
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 22, 2023

    "Don't Eat me" Signal in Hematological Malignancies: CD24 as New

    Recruiting
    • Mantle-cell Lymphoma
    • B Cell Chronic Lymphocytic Leukemia
      • Monza, MB, Italy
        Andrea Aroldi
      May 24, 2023

      Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive Trial in Houston (Acalabrutinib, Venetoclax)

      Recruiting
      • Blastoid Variant Mantle Cell Lymphoma
      • +8 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 5, 2022

      Mantle Cell Lymphoma, Ketogenic Dieting Trial in New York (Ketogenic Diet)

      Recruiting
      • Mantle Cell Lymphoma
      • Ketogenic Dieting
      • Ketogenic Diet
      • New York, New York
        Weill Cornell Medicine
      Oct 17, 2022

      Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

      Not yet recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • +5 more
      • Routine care as per site standard.
      • (no location specified)
      Sep 15, 2023